Clinical Trial

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Study acronym: SESAME
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-11
notable Primary completion moved earlier: 2026-11 -> 2026-10-01 2026-07-11
Trial Details
NCT Number NCT07556380
Lead Sponsor Northwestern University
Collaborators: National Institutes of Health (NIH), Huntsman Cancer Institute, National Cancer Institute (NCI)
Conditions Melanoma (Skin Cancer)
Enrollment 150 participants
Start Date 2025-04-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2027-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-10